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DESCRIPTION OF DANISH REGISTERS
The Danish National Prescription Registry
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Health, University of Southern Denmark, Denmark, 3Department of Clinical Epidemiology, Aarhus University Hospital,
Denmark, and 4Department of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark
Abstract
Introduction: Individual-level data on all prescription drugs sold in Danish community pharmacies has since 1994 been
recorded in the Register of Medicinal Products Statistics of the Danish Medicines Agency. Content: The register subset,
termed the Danish National Prescription Registry (DNPR), contains information on dispensed prescriptions, including
variables at the level of the drug user, the prescriber, and the pharmacy. Validity and coverage: Reimbursement-driven record
keeping, with automated bar-code-based data entry provides data of high quality, including detailed information on the
dispensed drug. Conclusion: The possibility of linkage with many other nationwide individual-level data sources
renders the DNPR a very powerful pharmacoepidemiological tool.
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Introduction
Since 1994, information on all prescription drugs
sold in Denmark has been recorded in the Register of
Medicinal Products Statistics (RMPS), maintained
by the Danish Medicines Agency [1]. From an
international perspective, the RMPS is unique,
providing individual-level information on dispensed
prescriptions for an entire nation since 1994. Similar
nationwide prescription registers have afterwards
been established in other Nordic countries [2].
In addition to prescription information, RMPS
contains aggregate data on sales of over-the-counter
(OTC) drugs and drugs sold for inpatient use. The
RMPS was established by law in order to create drug
price indexes and compile statistics for health author-
ities. Subsequent legalization enabled the use of the
individual-level data for research. Since 2003, the
prescription data in RMPS have been made available
for researchers through an encrypted copy of the
entire prescription register – except for the 1994
data, which are incomplete. This sub-register,
administered by Statistics Denmark, is termed the
Danish National Prescription Registry (DNPR). The
tracking of individual prescription histories over time
is made feasible by a unique personal identification
number (CPR-number), assigned to all residents at
birth or upon immigration, and it is included in all
national registers [3,4].
As described elsewhere in this supplementum,
researchers at authorized institutions can apply for
online access to extracts of individual-level registers
maintained or administered by Statistics Denmark,
including DNPR [5]. Before releasing data for
research, Statistics Denmark encrypts the original
CPR-number, permanently replacing it with another
identifier.
Content
DNPR contains information on all prescription
drugs dispensed at Danish community pharmacies.
Unlike prescription registers in other countries, the
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DNPR contains individual-level information on
prescriptions dispensed to residents of long-term
care institutions, such as nursing homes.
The variables in DNPR can be divided into four
main categories: variables related to drug user, to
prescriber, and drug and pharmacy variables.
(1) The individual drug user is identified by the
encrypted CPR-number. The person identifier
allows tracking of all prescriptions redeemed by the
same individual and enables linkage of prescription
data to other individual-level registers managed by
Statistics Denmark, such as socio-demographic and
inpatient registers.
(2) Information on prescribers is organized by their
practice or hospital department, and linked to infor-
mation on medical specialty (e.g., general practi-
tioner, hospital-based gastroenterologist). From
2003, the prescriber practice code has been made
available for researchers, provided no linkage is made
to identify the physician’s community.
(3) Each dispensed drug is identified by the Nordic
article number [6] of the drug formulation, which
codes information on trade name, pharmaceutical
form, strength, and package size. Through a linkage
to the World Health Organization’s Collaborating
Centre for Drug Statistics Methodology [7], it is
possible to establish the global Anatomical
Therapeutic Chemical classification (ATC) code,
identifying the dispensed drug in a five-level classi-
fication system, and the defined daily dose (DDD).
The DDD of the drug is its assumed average adult
daily maintenance dose administered for the main
indication as mono-therapy. The amount of drug
dispensed is expressed in terms of number of DDDs
per package, enabling researchers to assess trends in
drug consumption for different drugs within the same
category. More than 30 additional categories of drug
information are available in the DNPR, including
dispensing date, number of packages dispensed,
number of units per packet, dosage form and
strength, availability (e.g. dose dispensing), phar-
macy retail price, patient co-payment, and reim-
bursement codes.
(4) The individual pharmacies are identified by a
code.
A selection of the variables included in DNPR is
listed in Table I. The non-included variables are
mainly related to the administrative handling of the
prescription or its re-imbursement. They are avail-
able from Statistics Denmark upon request.
Although important for some researchers, DNPR
does not include the following information:
(i) Drugs sold without a prescription are not
recorded on an individual level. Thus, OTC pur-
chasing is generally not registered in DNPR. Yet,
OTC drugs may be dispensed on prescription for
chronic diseases to entitle the patient for reimburse-
ment, in which case they are recorded on the
individual level.
(ii) Drugs dispensed at hospitals for outpatient
treatment, such as anti-neoplastic drugs or HIV
drugs, are not registered in DNPR.
(iii) DNPR contains information only on redeemed
prescriptions. Thus, it does not document
prescriptions issued by a physician but not filled
(‘‘primary non-compliance’’).
(iv) The prescribed daily dose and the indication
for prescribing the drug have recently been added as
variables. Yet, the non-mandatory information is
entered as free text, which is not readily usable for
research.
DNPR has undergone only minor changes since its
initiation. All Danish pharmacies are still obliged to
register dispensed prescriptions electronically for
RMPS. Before 1996, drugs prescribed for children
under age 16 were registered as dispensed for their
mother (i.e. under her CPR-number). Since
1 January 1996 drugs prescribed for children have
been registered under the child’s own CPR-number.
Coverage and validity
The DNPR contains data on all prescriptions
dispensed for Danish residents at outpatient
Table I. Selected variables available in the Danish National
Prescription Register.
Variables related to Contents
Drug user Personal identification number (CPR-number)




Dispensing Date of dispensing





Number of dose units in package
Retail price
Number of prescription refills
Reimbursed amount and type
Dosing instruction (optional, in free text)
Indication for prescribing (optional,
in free text)
Prescriber Prescriber practice code
Pharmacy Dispensing pharmacy code
Non-included variables mainly relate to the administrative
handling of the prescription.
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pharmacies. The linkage through the unique
CPR-number to other individual-level data
sources enables researchers to identify and follow
prescriptions on the individual level over time at all
Danish pharmacies. Thus, for individuals with
permanent residence in Denmark, loss to follow-up
is unlikely.
Due to the closed-circuit character of the register,
few studies have assessed the completeness and
validity/reliability of DNPR by means of an external
standard [8,9]. Yet, several factors point towards a
high data quality.
As opposed to the physician’s recording of inpa-
tient data (diagnoses etc.) in administrative systems,
the registering of data for DNPR constitutes an
integral component of a pharmacist’s key function of
selling prescription drugs. This includes maintaining
the computerized reimbursement account on the
individual level. For all Danish inhabitants, the actual
amount of reimbursement depends on whether the
particular drug is reimbursable (decided by the
Danish Medicines Agency at the National Board of
Health) and on preceding out-of pocket expenses on
reimbursable drugs [10]. Thus, the universal reim-
bursement system provides a strong economic incen-
tive for recording all drugs dispensed. Increasing use
of internet pharmacies to obtain low-price drugs
may, however, undermine the completeness of
DNPR if a substantial proportion of dispensed
prescriptions begins to bypass registration.
All drug-packets are labelled with an optically
scanned barcode corresponding to the Nordic article
number that acts as linkage to other registers
containing all necessary information about the
drug. Thus, inter/intra observer and information
bias are very unlikely to occur in DNPR. In contrast
to assessment of medical diagnoses that may vary
substantially across medical practitioners, within the
same medical practitioner and over place/time (due
to time-dependent diagnostic criteria/procedures and
administrative practices), sold drugs are uniquely
defined through the barcode.
Generally, the concordance of register-based and
questionnaire-based data on drug use have been
reassuring [8,9]. Yet, the validity depends on the
extent to which the prescription information captures
what it was intended to measure in the particular
pharmacoepidemiological study. Thus, for drug
exposure studies the concern lies in the reliance on
prescription redemption as a surrogate measure for
the actual ingestion of the drug by the person for
whom it was prescribed. However, when redeemed
regularly, the drug is most likely being ingested.
When studying prescribing behaviour, the
uncertainty lies in the fact that prescriptions are not
necessarily redeemed (‘‘primary non-compliance’’).
Pharmacoepidemiological research and regional
prescription registers
The development of the pharmacoepidemiological
discipline in Denmark was pioneered at two research
institutions: the Department of Clinical
Epidemiology at Aarhus University and the
Department of Clinical Pharmacology/General
Practice at the University of Southern Denmark,
Odense [11]. In Aarhus, the research has primarily
focused on aetiological studies of adverse drug reac-
tions, with particular emphasis on fatal drug expo-
sure, whereas in Odense the focus has been on drug
utilization, quality indicators, and prescriber feed-
back. Each institution has developed its own regional
prescription register, covering the County of
Northern Jutland from 1989 and the County of
Funen from 1990, respectively. Both registers are
active today and have extended their coverage to
neighbouring regions.
The regional registers and the DNPR differ in
several important ways. While the DNPR includes all
prescriptions regardless of reimbursement status, the
regional registers exclusively cover reimbursable
prescription drugs. Consequently, non-reimbursable
prescription drugs, such as hypnotics and benzodi-
azepines, oral contraceptives, and certain antibiotics,
are not recorded in the regional registers. On the
other hand, the regional registers are considerably
more ‘‘open’’ than the DNPR. These registers are
allowed to give person-identifiable data to research-
ers upon approval from the Danish Data Protection
Agency. This opens possibilities for a wider range of
epidemiological studies on identifiable drug users
and permits validation of recorded prescription data
using external sources. Furthermore, it is possible to
use the regional data to provide feedback to
prescribers. The DNPR’s closed-circuit safety
approach precludes these activities. Finally, both
regional registers were established earlier the DNPR.
Conclusion
The Danish National Prescription Registry is one of
the few individual-level prescription registers that
cover an entire nation [2]. With its high quality
prescription data since 1995, and the potential for
linkage with other data sources, the register is
potentially one of the world’s most powerful phar-
macoepidemiological tools.
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